Skip to Content


In the US, Imatinib (imatinib systemic) is a member of the drug class BCR-ABL tyrosine kinase inhibitors and is used to treat Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Chronic Myelogenous Leukemia, Dermatofibrosarcoma Protuberans, Gastrointestinal Stromal Tumor, Hypereosinophilic Syndrome, Myelodysplastic Diseases, Myeloproliferative Disorders and Systemic Mastocytosis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent: Tyrosine kinase inhibitor

Chemical Names

alpha-(4-metyl-1-piperazinyl)-3'-[[4-(3-pyridyl)-2-pyrimidinyl]amino]-p-tolu-p-toluidide- (WHO)

Benzamide, 4-((4-metyl)-1-piperazinyl)metyl)-N-(4-metyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-

Foreign Names

  • Imatinibum (Latin)
  • Imatinib (German)
  • Imatinib (French)
  • Imatinib (Spanish)

Generic Names

Brand Names

  • Anzovip
    Zdravlje, Serbia
  • Cemivil
    Hikma, Tunisia
  • Egitinid
    Polfa Tarchomin, Bulgaria
  • Glivec
    Novartis, Egypt; Novartis, Lebanon; Novartis, Norway; Novartis, Tunisia; Novartis, Turkey
  • Imakrebin
    Alvogen, Estonia
  • Imatib
    Aspen, Argentina; Cipla, Egypt
  • Imatinib BioOrganics
    BioOrganics, Estonia
  • Imatinib Comercial Médica
    Comercial Médica, Colombia
  • Imatinib GP Pharm
    GP Pharm, Argentina
  • Imatinib Humax
    Humax Pharmaceutical, Colombia
  • Imatinib Sanoswiss
    SanoSwiss, Estonia
  • Imatinib Synthon
    Synthon, Estonia
  • Imatinib Zentiva
    Sanofi-aventis, Estonia
  • Imatis
    Deva, Turkey
  • Imavec
    Koçak, Turkey
  • Itivas
    Krka, Latvia
  • Meaxin
    Krka, Estonia
  • Mesinib
    Varifarma, Argentina
  • Mesylonib
    Miracalus, India
  • Mitinab
    Glenmark, India
  • Nibix
    Polfa Pabianice, Bulgaria
  • Tagonib
    Microsules Arg, Argentina
  • Tibaldix
    ICN, Estonia; PharmaSwiss, Latvia
  • Alvotinib
    Remedica, Bosnia & Herzegowina
  • Anzovip
    Zdravlje, Bosnia & Herzegowina
  • Biotinib
    Biotoscana, Colombia
  • Carevec
    CJ Cheiljedang, South Korea
  • Enliven
    Orion, Bangladesh
  • Gleevec
    Novartis, South Africa; Novartis Pharmaceuticals, Canada
  • Glinib
    Dong-A, South Korea
  • Glitive
    Hanmi, South Korea
  • Glivec
    Emra-Med, Austria; Grupo Novartis, Spain; Haemato Pharm, Austria; Inopha, Austria; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Bangladesh; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lithuania; Novartis, Malaysia; Novartis, Netherlands; Novartis, New Zealand; Novartis, Oman; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Taiwan; Novartis, Venezuela; Novartis, Vietnam; Novartis Europharm, Austria; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharmaceuticals, Australia
  • Glotib
    Korea United Pharm, South Korea
  • Imakrebin
    Alvogen, Netherlands; Remedica, Bulgaria
  • Imatin
    Procaps, Colombia
  • Imatinib Accord
    Accord Healthcare, United Kingdom
  • Imatinib Actavis
    Actavis, Netherlands
  • Imatinib Amomed
    Remedica, Bulgaria
  • Imatinib BioOrganics
    BioOrganics, Malta; BioOrganics, Netherlands; Synthon, Bulgaria
  • Imatinib Diamedia
    Synthon, Netherlands
  • Imatinib Elea
    Elea, Argentina
  • Imatinib Generics
    Generics, Netherlands
  • Imatinib Genthon
    Genthon, Netherlands
  • Imatinib Glenmark
    Glenmark, Bulgaria; Glenmark, Netherlands
  • Imatinib Kiron
    Kiron, Netherlands
  • Imatinib PharOS Generics
    PharOS, Netherlands
  • Imatinib Richter
    Gedeon Richter, Netherlands
  • Imatinib Synthon
    Synthon, Bulgaria; Synthon, Netherlands
  • Imatinib Teva
    Teva, Netherlands; Teva Pharma, Portugal
  • Imatinib Zentiva
    Remedica, Bulgaria; Zentiva, Netherlands
  • Imatinib-AFT
    AFT, New Zealand
  • Imatinib-Teva
    Teva Pharma, Switzerland
  • Inivec
    Samjin, South Korea
  • Leukivec
    Chong Kun Dang, South Korea
  • Leukovec
    Jeil, South Korea
  • Leutinib
    Vitalchem, Colombia
  • Leutipol
    Polpharma, Netherlands
  • Matib
    Humax Pharmaceutical, Colombia
  • Meaxin
    Krka, Bulgaria
    Remedica, Netherlands
  • Neoxell
    Remedica, Bulgaria
  • Plivatinib
    Pliva, Croatia (Hrvatska)
  • Prevec
    Bukwang, South Korea
  • Tibaldix
    PharmaSwiss, Netherlands
  • Timab
    LKM, Argentina
  • Vek
    Dosa, Argentina
  • Zeite
    Synthesis, Colombia
  • Ziatir
    Richmond, Argentina

International Drug Name Search


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.